Skip to main content
. 2021 Nov 18;26(46):2001537. doi: 10.2807/1560-7917.ES.2021.26.46.2001537

Table 1. Number of resistant and total number of isolates from intensive care units, by pathogen, eastern vs south-western Switzerland, 2009 (n = 3,187) and 2018 (n = 4,030).

2009 2018
East South-west p value East South-west p value
n/all n/all n/all n/all
MRSA 9/292 87/400 < 0.001 22/388 20/263 0.410
GRE 1/132 1/168 > 0.999* 14/333 5/293 0.113
ESCR-EC 31/411 35/528 0.678 114/730 65/500 0.232
ESCR-KP 11/139 7/157 > 0.999 34/280 18/171 0.439
CRE 12/833 5/729 0.234 81/1,324 26/851 0.002
Enterobacter spp. 11/12 5/5 Nd 64/81 18/26 Nd
Klebsiella pneumoniae 0/12 0/5 Nd 9/81 3/26 Nd
Escherichia coli 0/12 0/5 Nd 5/81 4/26 Nd
Other 1/12 0/5 Nd 3/81 1/26 Nd
CRPA 53/253 65/209 0.017 62/254 39/171 0.792
CRAB 7/21 3/17 0.460* 3/17 3/8 0.344*
TSRSM 4/65 2/68 0.434* 2/71 1/57 > 0.999*

CRAB: carbapenem-resistant Acinetobacter baumannii complex; CRE: carbapenem-resistant Enterobacterales; CRPA: carbapenem-resistant Pseudomonas aeruginosa; GRE: glycopeptid-resistant Enterococcus faecalis/faecium; ESCR-EC: extended-spectrum cephalosporin-resistant Escherichia coli; ESCR-KP: extended-spectrum cephalosporin-resistant Klebsiella pneumoniae; MRSA: meticillin-resistant Staphylococcus aureus; Nd: not done; TSRSM: trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia.

Please note that E. coli and K. pneumoniae isolates were used for both the analysis on ESCR and carbapenem resistance. p values (chi-squared or *Fisher's exact test ) ≤ 0.05 were considered statistically significant (in bold).